Report cover image

Pharmaceuticals in the Netherlands

Publisher MarketLine
Published Nov 20, 2025
Length 42 Pages
SKU # MTLN20768364

Description

Pharmaceuticals in the Netherlands

Summary

Pharmaceuticals in the Netherlands industry profile provides top-line qualitative and quantitative summary information including: market size (value and volume 2019-24, and forecast to 2029). The profile also contains descriptions of the leading players including key financial metrics and analysis of competitive pressures within the market.

Key Highlights
  • The pharmaceutical market includes sales of both prescriptions and over-the-counter (OTC) drugs. The market scope does not cover consumer healthcare and animal health products.
  • The Dutch pharmaceuticals market recorded revenues of $11.4 billion in 2024, representing a compound annual growth rate (CAGR) of 2.9% between 2019 and 2024.
  • The central nervous system drugs segment accounted for the market's largest proportion in 2024, with total revenues of $2.3 billion, equivalent to 20.1% of the market's overall value.
  • The Dutch pharmaceuticals market witnessed healthy growth in 2024, registering an annual growth of 5.5%.
Scope
  • Save time carrying out entry-level research by identifying the size, growth, and leading players in the pharmaceuticals market in the Netherlands
  • Use the Five Forces analysis to determine the competitive intensity and therefore attractiveness of the pharmaceuticals market in the Netherlands
  • Leading company profiles reveal details of key pharmaceuticals market players’ global operations and financial performance
  • Add weight to presentations and pitches by understanding the future growth prospects of the Netherlands pharmaceuticals market with five year forecasts by both value and volume
Reasons to Buy
  • What was the size of the Netherlands pharmaceuticals market by value in 2024?
  • What will be the size of the Netherlands pharmaceuticals market in 2029?
  • What factors are affecting the strength of competition in the Netherlands pharmaceuticals market?
  • How has the market performed over the last five years?
  • How large is the Netherlands’s pharmaceuticals market in relation to its regional counterparts?

Table of Contents

42 Pages
1 Executive Summary
1.1. Market value
1.2. Market value forecast
1.3. Category segmentation
1.4. Geography segmentation
1.5. Market rivalry
1.6. Competitive landscape
2 Market Overview
2.1. Market definition
2.2. Market analysis
3 Market Data
3.1. Market value
4 Market Segmentation
4.1. Category segmentation
4.2. Geography segmentation
5 Market Outlook
5.1. Market value forecast
6 Five Forces Analysis
6.1. Summary
6.2. Buyer power
6.3. Supplier power
6.4. New entrants
6.5. Threat of substitutes
6.6. Degree of rivalry
7 Competitive Landscape
7.1. Who are the leading players?
7.2. What are the strengths of leading players?
7.3. What are the recent developments in the market?
8 Company Profiles
8.1. Novartis AG
8.2. Pfizer Inc
8.3. Astellas Pharma Inc
9 Macroeconomic Indicators
9.1. Country data
10 Appendix
10.1. Methodology
10.2. Industry associations
10.3. Related MarketLine research
10.4. About MarketLine
List of Tables
Table 1: Netherlands pharmaceuticals market value: $ million, 2019-24
Table 2: Netherlands pharmaceuticals market category segmentation: % share, by value, 2019-24
Table 3: Netherlands pharmaceuticals market category segmentation: $ million, 2019-24
Table 4: Netherlands pharmaceuticals market geography segmentation: $ million, 2024
Table 5: Netherlands pharmaceuticals market value forecast: $ million, 2024-29
Table 6: Novartis AG: Key Facts
Table 7: Novartis AG: Annual Financial Ratios
Table 8: Novartis AG: Key Employees
Table 9: Pfizer Inc: Key Facts
Table 10: Pfizer Inc: Annual Financial Ratios
Table 11: Pfizer Inc: Key Employees
Table 12: Pfizer Inc: Key Employees Continued
Table 13: Astellas Pharma Inc: Key Facts
Table 14: Astellas Pharma Inc: Annual Financial Ratios
Table 15: Astellas Pharma Inc: Key Employees
Table 16: Netherlands Size of Population (Million), 2020-24
Table 17: Netherlands Real GDP (Constant 2010 Prices, $ Billion), 2020-24
Table 18: Netherlands GDP (Current Prices, $ Billion), 2020-24
Table 19: Netherlands Inflation, 2020-24
Table 20: Netherlands Consumer Price Index (Absolute), 2020-24
Table 21: Netherlands Exchange Rate, 2019-24
List of Figures
Figure 1: Netherlands pharmaceuticals market value: $ million, 2019-24
Figure 2: Netherlands pharmaceuticals market category segmentation: $ million, 2019-24
Figure 3: Netherlands pharmaceuticals market geography segmentation: % share, by value, 2024
Figure 4: Netherlands pharmaceuticals market value forecast: $ million, 2024-29
Figure 5: Forces driving competition in the pharmaceuticals market in the Netherlands, 2024
Figure 6: Drivers of buyer power in the pharmaceuticals market in the Netherlands, 2024
Figure 7: Drivers of supplier power in the pharmaceuticals market in the Netherlands, 2024
Figure 8: Factors influencing the likelihood of new entrants in the pharmaceuticals market in the Netherlands, 2024
Figure 9: Factors influencing the threat of substitutes in the pharmaceuticals market in the Netherlands, 2024
Figure 10: Drivers of degree of rivalry in the pharmaceuticals market in the Netherlands, 2024

Search Inside Report

Pricing

Currency Rates
How Do Licenses Work?

How Do Licenses Work?

The primary function of a report license is to define how many people within a company are authorized to use the purchased report. This is separate to how a report might be delivered. Unless specifically identified otherwise, the purchase option is Single User. Below is a helpful description of that license, along with a sampling of others most commonly offered.

  • This license allows only one user to have access to and to use/read the report. It is not one user at a time or one user group; it is an individual who will be reading and utilizing the report.

  • This license allows for the entire purchasing company to read and use the report. This is the license level that would allow for a report to be placed on an internal company shared drive for access by all employees of that direct company. This license does not extend to parent or sister company use.

  • This license is designed to allow an entire department within a company full access to a report. The departmental license is a great option for companies that have more than one location and the department is spread out all over the country/world

  • This license is for companies that have one location where they want the report to be accessible by all employees within that physical location.

  • This is the most flexible of the licensing options. Some publishers will allow you to get a license for a preset number of people (typically 5). These licenses are ideal for small work groups.

License options are at the discretion of each publisher. As such, not all licenses indicated above are available for every product. If you are uncertain of the best license for your needs or would like a license that is not proactively available, please contact us and we will be happy to assist.

Request A Sample
Head shot

Questions or Comments?

Our team has the ability to search within reports to verify it suits your needs. We can also help maximize your budget by finding sections of reports you can purchase.
Chat Now
Contact Us